JPMorgan Chase & Co’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-28
Closed 6174
2021
Q3
$0 Hold
28
﹤0.01% 5939
2021
Q2
$0 Hold
28
﹤0.01% 5779
2021
Q1
$0 Sell
28
-47,338
-100% ﹤0.01% 5493
2020
Q4
$205K Buy
47,366
+7,131
+18% +$30.9K ﹤0.01% 4139
2020
Q3
$166K Sell
40,235
-77,719
-66% -$321K ﹤0.01% 3820
2020
Q2
$302K Sell
117,954
-35,234
-23% -$90.2K ﹤0.01% 3506
2020
Q1
$443K Buy
153,188
+143,272
+1,445% +$414K ﹤0.01% 3342
2019
Q4
$38K Buy
9,916
+2,514
+34% +$9.63K ﹤0.01% 4314
2019
Q3
$38K Buy
7,402
+1,200
+19% +$6.16K ﹤0.01% 4339
2019
Q2
$37K Buy
6,202
+773
+14% +$4.61K ﹤0.01% 4373
2019
Q1
$39K Sell
5,429
-255
-4% -$1.83K ﹤0.01% 4319
2018
Q4
$49K Buy
5,684
+596
+12% +$5.14K ﹤0.01% 4272
2018
Q3
$102K Sell
5,088
-153,449
-97% -$3.08M ﹤0.01% 4114
2018
Q2
$4.1M Sell
158,537
-84,749
-35% -$2.19M ﹤0.01% 2353
2018
Q1
$5.81M Sell
243,286
-22,453
-8% -$537K ﹤0.01% 2111
2017
Q4
$9.01M Buy
265,739
+129,466
+95% +$4.39M ﹤0.01% 1877
2017
Q3
$2.84M Buy
136,273
+135,235
+13,028% +$2.82M ﹤0.01% 2473
2017
Q2
$18K Sell
1,038
-152,725
-99% -$2.65M ﹤0.01% 3946
2017
Q1
$2.69M Sell
153,763
-26,621
-15% -$466K ﹤0.01% 2452
2016
Q4
$3.05M Buy
180,384
+16,934
+10% +$286K ﹤0.01% 2451
2016
Q3
$2.68M Buy
163,450
+7,651
+5% +$126K ﹤0.01% 2320
2016
Q2
$2.36M Buy
155,799
+41,693
+37% +$631K ﹤0.01% 2379
2016
Q1
$1.65M Buy
114,106
+59,125
+108% +$855K ﹤0.01% 2454
2015
Q4
$1.56M Sell
54,981
-6,747
-11% -$191K ﹤0.01% 2499
2015
Q3
$1.03M Buy
61,728
+1,339
+2% +$22.4K ﹤0.01% 2659
2015
Q2
$1.58M Sell
60,389
-6,211
-9% -$163K ﹤0.01% 2618
2015
Q1
$1.17M Sell
66,600
-3,500
-5% -$61.2K ﹤0.01% 2767
2014
Q4
$1.22M Buy
70,100
+57,600
+461% +$1M ﹤0.01% 2709
2014
Q3
$233K Sell
12,500
-34,060
-73% -$635K ﹤0.01% 3236
2014
Q2
$851K Buy
+46,560
New +$851K ﹤0.01% 2843